-
Diagnostics World | Baylor College of Medicine will continue to create customized cell, fly, and mouse models to study rare genetic diseases; Curve Biosciences will advance the clinical validation and commercialization of their Whole-Body Intelligence platform for chronic disease monitoring; and more.
Nov 25, 2025
-
Diagnostics World | Royal Philips extended their partnership with Cortechs.ai; OCEAN Dx completes a clinical evaluation study for its innovative rapid diagnostic test for sepsis; Nucleai and the University of Glasgow announce a collaboration; and more.
Nov 24, 2025
-
Diagnostics World | Royal Philips extended their partnership with Cortechs.ai; OCEAN Dx completes a clinical evaluation study for its innovative rapid diagnostic test for sepsis; Nucleai and the University of Glasgow announce a collaboration; and more.
Nov 24, 2025
-
Diagnostics World | Watchmaker Genomics has launched TAPS+, a next-generation technology that unites genetic and epigenetic readouts from the same DNA molecule. By capturing multiple biological dimensions in a single assay, TAPS+ delivers a richer, more comprehensive view of tumor biology, with the power to advance applications in translational oncology, early cancer detection, therapy response monitoring, fragmentomics, and minimal residual disease assessment.
Nov 19, 2025
-
Diagnostics World | The Association for Molecular Pathology hosted its 2025 Annual Meeting & Expo last week. Highlights from some of the research presented at the event include faster molecular tests for dangerous regional fungal infections, new Lyme disease tests, AI tools for improving molecular diagnosis, new use for old DNA samples to understand the evolution of colorectal cancer, and more.
Nov 18, 2025
-
Diagnostics World | In a study published this week in Nature, researchers from Illumina and The University of Queensland demonstrated the importance of whole-genome sequencing (WGS) to more fully capture the genetics underlying complex human traits and diseases.
Nov 14, 2025
-
Diagnostics World | Even though roughly two-thirds of pivotal studies leading to FDA drug approvals now enroll women at rates aligned with their disease burden, their inclusion has “plateaued." Diagnostic criteria and disease models remain largely male-centered because they don’t take into account of the biological and hormonal rhythms that shape women’s health across their lives. That diagnostic blind spot reverberates throughout drug development.
Nov 12, 2025
-
Diagnostics World | Veterans of Illumina and Grail launched Hepta, a biotechnology company using transformer-based AI to read the cell-free DNA (cfDNA) epigenome and detect organ-specific signals of chronic disease. Hepta emerged from stealth with $6.7 million in seed funding.
Nov 11, 2025
-
Diagnostics World | For most physicians, concerns about artificial intelligence (AI) continue to outweigh enthusiasm for its potential to improve healthcare decision-making and patient outcomes. Doctors need to understand the reasons behind the predictions of AI tools if they’re expected to use the insights as a starting point for discussing treatment options with their patients.
Nov 6, 2025
-
Diagnostics World | NHS England is trialing a 15-minute blood test that can distinguish between bacterial or viral infections, identifying serious diseases like sepsis or meningitis quickly in children.
Nov 4, 2025